RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest
about
The transcription factor p53: not a repressor, solely an activatorResponse gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorH2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activityInfluence of cell cycle on responses of MCF-7 cells to benzo[a]pyreneResponse gene to complement 32 regulates the G2/M phase checkpoint during renal tubular epithelial cell repair.RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries.Responses of cultured human keratocytes and myofibroblasts to ethyl pyruvate: a microarray analysis of gene expressionResponse gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumorsIntegrative analysis of prostate cancer aggressiveness.The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells.Toxicogenomics directory of chemically exposed human hepatocytes.Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neckResponse gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3Whole-genome gene expression profiling reveals the major role of nitric oxide in mediating the cellular transcriptional response to ionizing radiation in normal human fibroblastsResponse gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovaryTemporal profiling of rat transcriptomes in retinol-replenished vitamin A-deficient testis.Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A.Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.Epigenetic modifications induced by RGC-32 in colon cancer.Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.The expression of response gene to complement 32 on renal ischemia reperfusion injury in rat.Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.TP53 Regulates Transcription of Cell Cycle GenesTP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertainEffects of antidepressant drug exposure on gene expression in the developing cerebral cortex.Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.RGC-32 (Response Gene to Complement 32 Protein) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.TP53 binds the RGCC geneTP53 stimulates RGCC expressionRenal proteomic analysis of RGC-32 knockout mice reveals the potential mechanism of RGC-32 in regulating cell cycle.Response Gene to Complement 32 in Vascular Diseases
P2860
00eb845c9e5fd9e8e2a02a494a337ad7db8d0b060e7cd482209d10a1c76df6750bda40c7e8332326187768c7f3fd96b88a1292768fcaf5ff4018a25f2a04b450ea01da0ab3288d0c1bff3a6b0e505ebb2ccbca3690acc5eb22c51b9299ac367484893a5f35c5fad14e710e191343482d8d3fa040cf77b33e7df046e2785676d968d668f6e9565b9b06dcdf66985430bdca97fecd597ad223f3f61540eae876ccb672aa4c9fac427302e2bd8a12c4e0c1b57c1c3eb7fb66f8a8441864fcdb43bb4ec75a2b207004b0ea1b70ddc3ddfdb2cb4740c46e6261e5b1b5b7fef402f4ac56eb18525aff4d20aa04a355e313b151
P248
Q24273295-A17000FE-024F-4D3C-8C95-CABF67856494Q24320745-7F48DE90-D0EF-4FC5-82E6-46118AE41F0DQ24651179-A684A730-74DF-4C1C-87A8-3028594BC3F2Q28390752-CEDBE8E9-3E15-4079-A62E-C3B8A212775AQ33634561-15050F98-69B6-46EA-B276-B87083A478B4Q33634647-5879B5A9-2434-480C-AEC0-DBD3B5E2A2F5Q33738887-CF76B071-B031-48A6-BCFD-8D1727A66909Q33780229-2E2F8D39-3E8A-493A-850A-B372ECB4B13EQ33938175-E6866193-0E7F-43EB-8CB5-32A22645E390Q34044591-FE51405C-8602-43C7-BAF9-0C0A69232954Q34097970-D008961F-F8C4-4D23-89DD-AE0BDEB548DFQ34452275-A27EE29E-1342-449A-8516-253DB63A85B8Q34787486-B5D416E3-D908-41D5-902A-F2B227EA26E0Q35116452-E8EFDF45-C36B-4E4C-AFF6-378217BF815FQ35423042-C53B4BB9-EB6D-44FE-AE2A-3DEF1BFBFDFEQ35575285-FD9E6001-9DDC-47BD-94AE-F15F18CCD980Q35914358-658D1CF2-E3E6-412D-A85F-E4469FB7EBC7Q36354395-DBBF6BBD-A876-473E-B8DF-DBCD41661357Q36473183-5B58ED74-DDA8-4907-90B6-DA82BA21AB0AQ36692147-980F69A1-7423-4F06-8CBA-529E23149C81Q37409482-815AD4A5-5027-4279-BE98-CA5D83C42CC5Q38068141-63C47748-517A-4B1E-9624-97B537D2A482Q38838114-1D5FDF66-1617-436B-ADD6-404EB2A57600Q38994477-C4937B59-A9DA-497C-ADAA-64E07A6CE526Q39780293-BCE98997-172B-4006-9E56-AF383CDCED71Q39855238-3163E13D-4A36-4827-86A7-1E5ABB9FE172Q40114074-41D6BFC7-0F0C-4A24-9CC5-D5619E762F24Q40227380-8EE17FD4-6095-4F46-ACEB-2E520A19AA6EQ43266310-0FA32E2D-8C27-4AF5-A2F3-381536F2B856Q45316777-A7231216-6BBF-41EA-9DF4-CFCDF1CCB47DQ45316781-E10C74E1-A4B9-45FE-B45C-16153738FD21Q46011308-1744D14E-E169-49E6-8366-9DABE86FB9E2Q47547593-123BA3E3-CF26-42E4-8B00-F90F2AA75C8AQ47930819-4C93FB5A-7541-434B-AFF6-1B44302E1096Q49960681-85300A3C-06C1-4FAA-B779-CBB3FEC9E37FQ50290292-0383BD6E-D568-4681-B21E-D110948AA83CQ50290293-7271E97E-1B1D-47BF-A02D-54B3C4635531Q52720151-4F52F366-C2B3-4BB9-BF66-EFE5B9D9A9AFQ57073642-9B85A9D8-4946-450D-882D-8BAE53A54E92
P2860
RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@ast
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en-gb
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@nl
type
label
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@ast
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en-gb
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@nl
prefLabel
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@ast
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en-gb
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@nl
P2093
P2860
P921
P356
P1433
P1476
RGC32, a novel p53-inducible g ...... sis and results in G2/M arrest
@en
P2093
C Tanikawa
Y Nakamura
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210148
P407
P577
2007-02-22T00:00:00Z
P5875
P6179
1023492345